Aptamer-antibody hybrid ELONA that uses hybridization chain reaction to detect a urinary biomarker EN2 for bladder and prostate cancer
Crossref DOI link: https://doi.org/10.1038/s41598-022-15556-1
Published Online: 2022-07-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Eunseon
Kang, Minji
Ban, Changill
Text and Data Mining valid from 2022-07-07
Version of Record valid from 2022-07-07
Article History
Received: 28 January 2022
Accepted: 27 June 2022
First Online: 7 July 2022
Competing interests
: The authors declare no competing interests.